Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 9, 2025Moldovan Journal of Health Sciences

Sarcopenia and frailty: risk profiles in patients with chronic heart failure

View Full Paper
Ask AI
Bookmark
Share

Authors

AIAnastasia IvanesLMLucia Mazur-NicoriciVSV. Salaru

Discussion

Loading...

Member takes

Overview

Cross-sectional study evaluates sarcopenia and frailty risk factors in heart failure patients, indicating cardiovascular inflammation impacts outcomes.

Key Points

  • Sarcopenia was prevalent in 56.8% of frail patients with chronic heart failure, particularly affecting women.
  • About 88.9% of patients had functional impairment, with severe sarcopenia solely found among women.
  • Patients with sarcopenia experienced higher rates of hypertension, diabetes, and obesity, showing significant metabolic comorbidities.
  • C-reactive protein and NT-proBNP levels were associated with sarcopenia risk, emphasizing inflammation's role in heart failure.

Cite This Study

Ivanes et al. (2025) studied this question.

synapsesocial.com/papers/68e70da790569dd607ee5b1ehttps://doi.org/10.52645/mjhs.2025.3.13
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The sarcopenia and frailty conundrum in heart failure: a clinical perspective from the FREE registry2026 · 3 citations
  2. 2Prevalence of sarcopenia in heart failure with mildly reduced ejection fraction and its impact on clinical outcomes2024 · 8 citations
  3. 3Prevalence of sarcopenia and its association with clinical outcomes in heart failure: An updated meta‐analysis and systematic review2023 · 68 citations
  4. 4Sarcopenia defined by multidimensional factors and its prognostic role in heart failure: a systematic review and meta-analysis2025 · 4 citations
  5. 5Prevalence of Sarcopenia in Chronic Heart Failure and Modulating Role of Chronic Kidney Disease2024 · 7 citations